Oryzon Genomics S.A. (0RDB.L)

EUR 2.68

(2.88%)

Inventory Summary of Oryzon Genomics S.A.

  • Oryzon Genomics S.A.'s latest annual inventory in 2023 was 6655.99 USD , down -36.56% from previous year.
  • Oryzon Genomics S.A.'s latest quarterly inventory in 2024 Q2 was 7632.57 USD , down 0.0% from previous quarter.
  • Oryzon Genomics S.A. reported annual inventory of 10.49 Thousand USD in 2022, down -91.12% from previous year.
  • Oryzon Genomics S.A. reported annual inventory of 118.13 Thousand USD in 2021, down -69.48% from previous year.
  • Oryzon Genomics S.A. reported quarterly inventory of 7396.33 USD for 2023 Q2, down 0.0% from previous quarter.
  • Oryzon Genomics S.A. reported quarterly inventory of 6655.99 USD for 2023 Q4, down 0.0% from previous quarter.

Annual Inventory Chart of Oryzon Genomics S.A. (2023 - 2012)

Historical Annual Inventory of Oryzon Genomics S.A. (2023 - 2012)

Year Inventory Inventory Growth
2023 6655.99 USD -36.56%
2022 10.49 Thousand USD -91.12%
2021 118.13 Thousand USD -69.48%
2020 387.04 Thousand USD 19.47%
2019 323.95 Thousand USD 110.25%
2018 154.08 Thousand USD 1665.12%
2017 8729.45 USD -0.45%
2016 8768.55 USD 105.18%
2015 4273.69 USD -60.51%
2014 10.82 Thousand USD 255.87%
2013 3040.69 USD -83.84%
2012 18.81 Thousand USD 0.0%

Peer Inventory Comparison of Oryzon Genomics S.A.

Name Inventory Inventory Difference
Boiron SA 96.76 Million EUR 99.993%
Laboratorios Farmaceuticos Rovi, S.A. 337.96 Million EUR 99.998%
Vetoquinol SA 103.53 Million EUR 99.994%
Valneva SE 44.46 Million EUR 99.985%
AB Science S.A. 336 Thousand EUR 98.019%
Nanobiotix S.A. 200 Thousand EUR 96.672%
PHAXIAM Therapeutics S.A. 671 Thousand EUR 99.008%
Vivoryon Therapeutics N.V. 1.00 EUR -665499.0%
BioSenic S.A. - EUR -Infinity%
ABIVAX Société Anonyme 1.00 EUR -665499.0%
Formycon AG 467 Thousand EUR 98.575%